Massimiliano Fonsi - Concepedia

Author

Massimiliano Fonsi

IRBM Science Park ORCID

Also Known As

Fonsi, M., M. Fonsi, Massimiliano Fonsi

Publications

696

Citations

H-Index

Concepts

All Affiliations

IRBM Science Park

About

Massimiliano Fonsi is an author at IRBM Science Park specializing in drug discovery, medicinal chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	119
2	Natural Sciences	2	2	57
3	Biochemistry	2	2	57
4	Chemical Biology	1	1	12
5	Pathology	1	1	37

Massimiliano Fonsi

Publications

680

Citations

H-Index

Page 1

	Year	Citations
Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors Philip Jones, Sergio Altamura, Julia K. Boueres, Journal of Medicinal Chemistry	2009	305
Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Journal of Pharmacology and Experimental Therapeutics	2014	69
Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors Ester Muraglia, Olaf Kinzel, Cristina Gardelli, Journal of Medicinal Chemistry	2008	52
Discovery of a Potent Class I Selective Ketone Histone Deacetylase Inhibitor with Antitumor Activity in Vivo and Optimized Pharmacokinetic Properties Olaf Kinzel, Laura Llauger-Bufi, Giovanna Pescatore, Journal of Medicinal Chemistry Drug TargetAntitumor ActivityPharmacotherapyPharmaceutical ChemistryDrug Resistance	2009	45
High-Throughput Microsomal Stability Assay for Screening New Chemical Entities in Drug Discovery Massimiliano Fonsi, Maria Vittoria Orsale, Edith Monteagudo SLAS DISCOVERY	2008	40
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, Part 2 Olaf Kinzel, Anna B. Alfieri, Sergio Altamura, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryPart 2MedicinePathology	2011	37
Intra-Articular Hyaluronic Acid and Chondroitin Sulfate: Pharmacokinetic Investigation in Osteoarthritic Rat Models Massimiliano Fonsi, Abdel-Ilah El Amrani, Frédéric Gervais, Current Therapeutic Research	2019	34
N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists Ester Muraglia, Jesus M. Ontoria, Danila Branca, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacological AgentPharmacotherapyHeterocycle Chemistry	2011	25
Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221 Maria Teresa Di Martino, Mariamena Arbitrio, Massimiliano Fonsi, Cancers	2019	19
The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease Edith Monteagudo, Massimiliano Fonsi, Xiaoyan Chu, Xenobiotica	2010	17

Page 1